Different Strategies to Execute Multi‐Database Studies for Medicines Surveillance in Real‐World Setting: A Reflection on the European Model

Abstract

on behalf of the Working Group 3 of ENCePP (Inventory of EU data sources and methodological approaches for multisource studies) Although postmarketing studies conducted in population-based databases often contain information on patients in the order of millions, they can still be underpowered if outcomes or exposure of interest is rare, or the interest is in subgroup effects. Combining several databases might provide the statistical power needed. A multi-database study (MDS) uses at least two healthcare databases, which are not linked with each other at an individual person level, with analyses carried out in parallel across each database applying a common study protocol. Although many MDSs have been performed in Europe in the past 10 years, there is a lack of clarity on the peculiarities and implications of the existing strategies to conduct them. In this review, we identify four strategies to execute MDSs, classified according to specific choices in the execution: (A) local analyses, where data are extracted and analyzed locally, with programs developed by each site; (B) sharing of raw data, where raw data are locally extracted and transferred without analysis to a central partner, where all the data are pooled and analyzed; (C) use of a common data model with study-specific data, where study-specific data are locally extracted, loaded into a common data model, and processed locally with centrally developed programs; and (D) use of general common data model, where all local data are extracted and loaded into a common data model, prior to and independent of any study protocol, and protocols are incorporated in centrally developed programs that run locally. We illustrate differences between strategies and analyze potential implications.

Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project

“…A distributed analyses approach based on a “study-specific” common data model (CDM) strategy was used [ 24 ]. An R-based open-source tool “TheShinISS,” developed by the Italian National Institute of Health for conduction of distributed analyses and described elsewhere [ 14 , 25 – 27 ], was customized for the purposes of the study.…”

Challenges for Drug Repurposing in the COVID-19 Pandemic Era

“…Depending on the heterogeneity or similarity of the information available, results can be meta-analyzed or pooled with data from different sources with the same objectives. Multi-database studies are becoming increasingly important as their potential in reaching large sample sizes over a short observation period is recognized (Gini et al, 2020). Indeed, it is internationally acknowledged that having a stable multi-database network to rapidly provide almost real-time healthcare information to regulatory and public health agencies is very important (Sultana et al, 2020b).…”

A common data model for harmonization in the Nordic Pregnancy Drug Safety Studies (NorPreSS)

“…In a workshop report from a 2017 meeting at the European Medicines Agency, a CDM was defined as, "…a mechanism by which raw data are standardised to a common structure, format and terminology independently from any particular study in order to allow a combined analysis across several databases/datasets" (EMA 2018). Gini et al (2020) called this "a general CDM". A general CDM is made prior to and independent of any study protocol.…”